Patents by Inventor Kylene Wesley Kehn-Hall

Kylene Wesley Kehn-Hall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alphavirus and compositions, methods, and kits related thereto
    Patent number: 11406699
    Abstract: The present invention provides modified alphaviruses and compositions, methods, and kits for preparing and using them to elicit an immune response to an alphavirus in a subject.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: August 9, 2022
    Assignee: George Mason University
    Inventors: Kylene Wesley Kehn-Hall, Brian D. Carey, Ivan V. Akhrymuk, Caitlin W. Lehman
  • PERK AS A TARGET FOR VIRUS THERAPEUTICS
    Publication number: 20220202849
    Abstract: The present disclosure provides compositions and methods for modulating PERK activity and/or expression in cells for use in treatment or prevention of viral infection, including by reducing translation of viral non-structural proteins in cells using compositions and/or compounds that inhibit PERK activity and/or expression.
    Type: Application
    Filed: October 8, 2021
    Publication date: June 30, 2022
    Applicant: George Mason University
    Inventors: Kylene Wesley KEHN-HALL, Bibha DAHAL, Jonathan DINMAN, Jonathan Larson Jacobs
  • ALPHAVIRUS AND COMPOSITIONS, METHODS, AND KITS RELATED THERETO
    Publication number: 20200297834
    Abstract: The present invention provides modified alphaviruses and compositions, methods, and kits for preparing and using them to elicit an immune response to an alphavirus in a subject.
    Type: Application
    Filed: March 16, 2020
    Publication date: September 24, 2020
    Applicant: George Mason University
    Inventors: Kylene Wesley Kehn-Hall, Brian D. Carey, Ivan V. Akhrymuk, Caitlin W. Lehman